Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide

In "Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide," Dr. Curlin details what a normal post-vaccination reaction looks like, and when a symptom warrants concern.

Dr. Jeff Goad turns to a common pharmacy scenario: patients who felt unwell after a prior COVID-19 dose and want to know whether that reaction was normal. He asks Curlin how pharmacists can help patients distinguish an expected post-vaccination reaction from something requiring medical attention.

Curlin outlines a clear timeline for typical immune responses. Standard reactions generally develop within six to twenty-four hours after vaccination, he explains, and wane by about seventy-two hours at the outside. These expected symptoms include systemic effects like fever and fatigue, along with local effects such as swelling, redness, and arm soreness. Symptoms that fall outside that window deserve closer attention, Curlin says. Reactions appearing within the first few minutes after injection, or new symptoms emerging weeks later, fall outside the typical immune response pattern. He specifically flags throat swelling, numbness, longer-term neurologic effects, and heart palpitations as symptoms that warrant a visit to a healthcare provider.

Goad raises a specific concern many parents share: myocarditis and pericarditis in adolescents, particularly boys. Curlin explains these conditions involve inflammation of the heart muscle or the sac surrounding it. They are typically treated with non-steroidal anti-inflammatory medications and tend to be self-limited, he says, though uncomfortable while they last. Curlin stresses that these events are exceedingly rare. Patients with a prior history of myocarditis or pericarditis should consult their physician before future vaccination, he advises, and anyone experiencing chest pain or palpitations for any reason should seek medical evaluation.

Curlin closes by putting these rare risks into perspective. He notes that these events occur in only a small fraction of a million vaccinated people. That risk, he says, is dramatically lower than the risk of long COVID, hospitalization, ventilatory support, or death from the natural infection itself.

Our next episode, "Validating Fear Before Facts: A Framework for COVID-19 Hesitancy," offers a framework for meeting a patient's unspoken fears before presenting the evidence.